Armida W. M. Fabius

3.5k citations

24 papers · 2.5k indexed · 1 hit paper · h-index 15

Molecular Biology top 5%
Genetics top 0.5%
Cancer Research top 2%
Oncology top 10%
Pulmonary and Respiratory Medicine top 10%

Co-authors: Şevin Turcan Jason T. Huse Agnès Viale Craig B. Thompson Timothy A. Chan Patrick S. Ward Olga A. Guryanova Chao Lü
Topics: Ocular Oncology and Treatments (12 papers)Glioma Diagnosis and Treatment (9 papers)Epigenetics and DNA Methylation (6 papers)
Cited by: Genetics Cancer Research Ophthalmology
Journals: Nature Proceedings of the National Academy of Sciences Nature Genetics
Partner nations: Netherlands United States Switzerland

In The Last Decade

Armida W. M. Fabius

22 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

2012 1.4k citations Şevin Turcan, Daniel Rohle et al. Nature profile →

Peers

Countries citing papers authored by Armida W. M. Fabius

Since Specialization

Citations

This map shows the geographic impact of Armida W. M. Fabius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armida W. M. Fabius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armida W. M. Fabius more than expected).

Fields of papers citing papers by Armida W. M. Fabius

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Armida W. M. Fabius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armida W. M. Fabius. The network helps show where Armida W. M. Fabius may publish in the future.

Co-authorship network of co-authors of Armida W. M. Fabius

This figure shows the co-authorship network connecting the top 25 collaborators of Armida W. M. Fabius. A scholar is included among the top collaborators of Armida W. M. Fabius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Armida W. M. Fabius. Armida W. M. Fabius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	At What Age Could Screening for Familial Retinoblastoma Be Stopped? 2025 ·Ophthalmology ·(unknown),Milo van Hoefen Wijsard,Charlotte J. Dommering,Stéphanie van der Pas,Machteld I. Bosscha,Armida W. M. Fabius,Annette C. Moll	0
2	High-Level MYCN-Amplified RB1-Proficient Retinoblastoma Tumors Retain Distinct Molecular Signatures 2022 ·SHILAP Revista de lepidopterología ·(unknown),Yvonne de Jong,Saskia E. van Mil,Armida W. M. Fabius,Annette C. Moll,Josephine C. Dorsman	12
3	Subsequent Malignant Neoplasms in Retinoblastoma Survivors 2021 ·Cancers ·Armida W. M. Fabius,Milo van Hoefen Wijsard,Flora E. van Leeuwen,Annette C. Moll	16
4	At What Age Could Screening for Familial Retinoblastoma Be Discontinued? A Systematic Review 2021 ·Cancers ·Milo van Hoefen Wijsard,(unknown),René H.J. Otten,Machteld I. Bosscha,Charlotte J. Dommering,Armida W. M. Fabius,Annette C. Moll	4
5	Benign Tumors in Long-Term Survivors of Retinoblastoma 2021 ·Cancers ·Milo van Hoefen Wijsard,Sara J. Schonfeld,Flora E. van Leeuwen,Annette C. Moll,Armida W. M. Fabius,David H. Abramson,Johanna M. Seddon,Jasmine H. Francis,Margaret A. Tucker,Ruth A. Kleinerman,Lindsay M. Morton	4
6	Second primary malignancies in retinoblastoma patients treated with intra-arterial chemotherapy: the first 10 years 2017 ·British Journal of Ophthalmology ·Larissa A. Habib,Jasmine H. Francis,Armida W. M. Fabius,Pierre Gobin,Ira J. Dunkel,David H. Abramson	17
7	Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistence 2017 ·Nature Genetics ·Şevin Turcan,Vladimir Makarov,Julián Taranda,Yuxiang Wang,Armida W. M. Fabius,Wei Wu,Yupeng Zheng,(unknown),Sara Haddock,Gouri J. Nanjangud,H. Carl LeKaye,Cameron Brennan,Justin R. Cross,Jason T. Huse,Neil L. Kelleher,Pavel Osten,Craig B. Thompson,Timothy A. Chan	140
8	Feasibility of RetinoQuest: e-health application to facilitate and improve additional care for retinoblastoma survivors 2017 ·Journal of Cancer Survivorship ·(unknown),Wijnanda A. Kors,Machteld I. Bosscha,(unknown),Armida W. M. Fabius,(unknown),Irma M. Verdonck‐de Leeuw,Annette C. Moll	4
9	Simultaneous Bilateral Ophthalmic Artery Chemosurgery for Bilateral Retinoblastoma (Tandem Therapy) 2016 ·PLoS ONE ·David H. Abramson,Brian P. Marr,Jasmine H. Francis,Ira J. Dunkel,Armida W. M. Fabius,Scott E. Brodie,(unknown),Y. Pierre Gobin	44
10	OCULAR PHARMACOLOGY OF CHEMOTHERAPY FOR RETINOBLASTOMA 2016 ·Retina ·Paula Schaiquevich,Armida W. M. Fabius,Jasmine H. Francis,Guillermo Chantada,David H. Abramson	31
11	Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC 2015 ·PLoS ONE ·David H. Abramson,Armida W. M. Fabius,Reda Issa,Jasmine H. Francis,Brian P. Marr,Ira J. Dunkel,Y. Pierre Gobin	65
12	Abstract 521: Glioma-associated IDH mutation induces miR-34a repression and stem cell-like physiology through enhanced PDGF signaling 2014 ·Cancer Research ·Joachim Silber,Girish Harinath,Prasanna Tamarapu Parthasarathy,Armida W. M. Fabius,Şevin Turcan,Timothy A. Chan,Jason T. Huse	0
13	Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine 2013 ·Oncotarget ·Şevin Turcan,Armida W. M. Fabius,Alexandra Borodovsky,Alicia Pedraza,Cameron Brennan,Jason T. Huse,Agnès Viale,Gregory J. Riggins,Timothy A. Chan	191
14	IDH1 mutation is sufficient to establish the glioma hypermethylator phenotypebreakdown → 2012 ·Nature ·Şevin Turcan,Daniel Rohle,Anuj Goenka,Logan A. Walsh,Fang Fang,Emrullah Yilmaz,Carl Campos,Armida W. M. Fabius,Chao Lü,Patrick S. Ward,Craig B. Thompson,Andrew Kaufman,Olga A. Guryanova,Ross L. Levine,Adriana Heguy,Agnès Viale,Luc G.T. Morris,Jason T. Huse,Ingo K. Mellinghoff,Timothy A. Chan	1382
15	Protein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase a oncogene 2012 ·Molecular Cancer ·Maria Meehan,(unknown),Niamh Moran,Caroline A. Jefferies,Niamh H. Foley,Elisa Lazzari,Derek Murphy,Jacqueline Ryan,(unknown),Armida W. M. Fabius,Timothy A. Chan,Raymond L. Stallings	35
16	Interleukin-1R–Associated Kinase 2 Is a Novel Modulator of the Transforming Growth Factor β Signaling Cascade 2010 ·Molecular Cancer Research ·Jasper Mullenders,Armida W. M. Fabius,(unknown),Hendrik J. Kuiken,Roderick L. Beijersbergen,René Bernards	1
17	A Large Scale shRNA Barcode Screen Identifies the Circadian Clock Component ARNTL as Putative Regulator of the p53 Tumor Suppressor Pathway 2009 ·PLoS ONE ·Jasper Mullenders,Armida W. M. Fabius,Mandy Madiredjo,René Bernards,Roderick L. Beijersbergen	109
18	An shRNA barcode screen provides insight into cancer cell vulnerability to MDM2 inhibitors 2006 ·Nature Chemical Biology ·Thijn R. Brummelkamp,Armida W. M. Fabius,Jasper Mullenders,Mandy Madiredjo,Arno Velds,Ron Kerkhoven,René Bernards,Roderick L. Beijersbergen	152
19	Functional Identification of Cancer-relevant Genes through Large-Scale RNA Interference Screens in Mammalian Cells 2004 ·Cold Spring Harbor Symposia on Quantitative Biology ·Thijn R. Brummelkamp,Katrien Berns,E. Marielle Hijmans,Jasper Mullenders,Armida W. M. Fabius,(unknown),Arno Velds,Ron Kerkhoven,Mandy Madiredjo,René Bernards,Roderick L. Beijersbergen	15
20	[Kinetocardiogram; its value in the examination of cardiac function]. 1967 ·PubMed ·(unknown),(unknown),(unknown),(unknown),Armida W. M. Fabius,(unknown),(unknown)	1

About Armida W. M. Fabius

Armida W. M. Fabius is a scholar working on Ophthalmology, Genetics and Aging, having authored 24 papers that have together received 2.5k indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (12 papers), Glioma Diagnosis and Treatment (9 papers) and Epigenetics and DNA Methylation (6 papers). The work is most often cited by research in Genetics (1.1k citations), Cancer Research (933 citations) and Ophthalmology (222 citations). Armida W. M. Fabius has collaborated with scholars based in Netherlands, United States and Switzerland. Frequent co-authors include Şevin Turcan, Jason T. Huse, Agnès Viale, Craig B. Thompson, Timothy A. Chan, Patrick S. Ward, Olga A. Guryanova, Chao Lü, Emrullah Yilmaz and Logan A. Walsh. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact